Published in Virus Weekly, April 5th, 2005
The Digene HPV Test, also known as the DNAwithPap Test, is, according to the company, the only U.S. Food and Drug Administration (FDA)-approved test for high-risk types of HPV, which cause virtually all cases of cervical cancer. The test is approved for use along with the Pap test to screen women age 30 and older, the group most at risk of developing cervical cancer.
Underscoring the need for a direct-to-consumer educational...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.